Maalox RefluRAPID

Maalox RefluRAPID is a medical device designed to treat gastroesophageal reflux symptoms, such as heartburn and acid regurgitation. The Maalox brand has its roots in the United States, where it was originally developed as a combination of magnesium and aluminum hydroxides.

Today, Maalox is a globally recognized brand in the consumer healthcare sector. It is owned by Sanofi, a leading French multinational pharmaceutical company. While the brand has American origins, the specific RefluRAPID line is heavily marketed in European markets like Italy and is manufactured in large-scale pharmaceutical facilities across Europe to meet regional demand.